secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001770787-23-000034
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve director elections, auditor, and say-on-pay at 2023 annual meeting
--------------------------------------------------------------------------------

- Three Class I directors elected: Hindson, Saxonov, Stuelpnagel, each with >88% votes for.
- Ratification of Ernst & Young as independent auditor for FY2023 approved (99.9% votes for).
- Non-binding advisory vote on executive compensation passed with ~82% support (188M for, 39M against).
- Quorum achieved with 85.5% of eligible votes represented (238.3M of 278.8M votes).
- All proposals passed; no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078723000034/0001770787-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078723000034/txg-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001770787-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer